June 11, 2025Biogen Inc. Presents Exciting Advances at Goldman Sachs Conference ~1 min.Biogen Inc. recently presented at the Goldman Sachs 46th Annual Global Healthcare Conference, showcasing their latest innovations in the healthcare sector....
April 7, 2025Biogen Inc. Stock Hits Price Target Forecast on QuantWave, Generating 13.05% Profit ~1 min.In a recent development on QuantWave, the stock of Biogen Inc. has successfully reached the price target forecast, resulting in a profitable outcome for users....
April 6, 2025Biogen Inc. Continues to Struggle with Declining Earnings and Investor Returns ~2 min.Biogen Inc., a leading biotechnology company, has reported a significant decrease in company earnings, losing a staggering US$697 million....
April 4, 2025Biogen Inc. Stock Hits QuantWave Forecast Target with 11.12% Profit ~2 min.Biogen Inc. stock recently achieved the price target forecast set by QuantWave, signaling a successful prediction for investors....
April 4, 2025Biogen Inc. Hits Price Target Forecast on QuantWave with 12.72% Profit ~1 min.Biogen Inc. has successfully reached the price target forecast set by QuantWave, resulting in a profit of 12.72%. The forecast signal was issued on March 21, 2025, when the stock was priced at 140.9 $....
October 31, 2024AstraZeneca PLC Collaborates with Monopar Therapeutics on Rare Disease Treatment ~1 min.Monopar Therapeutics, a biopharmaceutical company specializing in rare disease treatments, has announced a groundbreaking partnership with AstraZeneca PLC....
December 18, 2024AbbVie Inc. ABBV to Acquire Nimble Therapeutics in a Game-Changing Move ~1 min.AbbVie Inc., a leading biopharmaceutical company, has announced its acquisition of Nimble Therapeutics, a pioneer in the field of immunology....
January 29, 2025AbbVie Inc. Completes Acquisition of Nimble Therapeutics ~2 min.AbbVie Inc., a global biopharmaceutical company, has successfully completed its acquisition of Nimble Therapeutics, a biotherapeutics discovery company....
January 31, 2025Biogen Inc. Receives FDA Approval for LEQEMBI as a Treatment for Early Alzheimer's Disease ~2 min.Biogen Inc., a leading biotechnology company, has announced that its drug LEQEMBI (lecanemab-irmb) has received approval from the U.S....
December 20, 2024Bristol-Myers Squibb Continues to Reward Investors, Announces Increased Dividend ~1 min.Bristol-Myers Squibb Company (NYSE:BMY) has just announced that it will be paying a larger dividend than last year, showing its commitment to rewarding its shareholders....
